 |
Size ($ in 1000's)
At 12/31/2023: $2,089,116
At 09/30/2023: $1,714,348
Combined Holding Report Includes:
Cormorant Asset Management LP
Chen Bihua
Cormorant Asset Management LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Cormorant Asset Management LP 13F filings.
Link to 13F filings: SEC filings
|
|
|
As of 12/31/2023, below is a summary of the Cormorant Asset Management LP top holdings by largest position size, as per the latest 13f filing made by Cormorant Asset Management LP.
In the Cormorant Asset Management LP-top-holdings-table below, each of the top holdings by name is presented in the first column, followed by the amount of shares
held by Cormorant Asset Management LP in that top holding, then the share count change between reporting periods, and finally the Cormorant Asset Management LP top holding position size
for that row.
| Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size
($ in 1000's) |
|---|
| MOONLAKE IMMUNOTHERAPEUTICS |
8,494,151 |
+352,051 |
$512,962 | | MLTX | 8,494,151 | +352,051 | $512,962 | | AMBRX BIOPHARMA INC |
11,231,000 |
+1,307,311 |
$159,929 | | AMAM | 11,231,000 | +1,307,311 | $159,929 | | EYEPOINT PHARMACEUTICALS INC |
6,038,235 |
+2,838,235 |
$139,544 | | EYPT | 6,038,235 | +2,838,235 | $139,544 | | BRIDGEBIO PHARMA INC |
3,344,179 |
-1,318,351 |
$135,005 | | BBIO | 3,344,179 | -1,318,351 | $135,005 | | ARCELLX INC |
1,700,000 |
-450,000 |
$94,350 | | ACLX | 1,700,000 | -450,000 | $94,350 | | RAYZEBIO INC |
1,213,478 |
+31,215 |
$75,442 | | RYZB | 1,213,478 | +31,215 | $75,442 | | BIOMEA FUSION INC |
3,570,872 |
UNCH |
$51,849 | | BMEA | 3,570,872 | UNCH | $51,849 | | IMMUNOVANT INC |
1,165,000 |
-60,000 |
$49,081 | | IMVT | 1,165,000 | -60,000 | $49,081 | | ALPINE IMMUNE SCIENCES INC |
2,550,000 |
+650,000 |
$48,603 | | ALPN | 2,550,000 | +650,000 | $48,603 | | PHARVARIS N V |
1,711,460 |
+350,000 |
$48,006 | | PHVS | 1,711,460 | +350,000 | $48,006 | | ALX ONCOLOGY HLDGS INC |
3,142,079 |
+2,530,000 |
$46,786 | | ALXO | 3,142,079 | +2,530,000 | $46,786 | | TARSUS PHARMACEUTICALS INC |
2,221,422 |
-400,000 |
$44,984 | | TARS | 2,221,422 | -400,000 | $44,984 | | CYMABAY THERAPEUTICS INC |
1,800,000 |
-2,050,000 |
$42,516 | | CBAY | 1,800,000 | -2,050,000 | $42,516 | | VAXCYTE INC |
665,000 |
UNCH |
$41,762 | | PCVX | 665,000 | UNCH | $41,762 | | CRINETICS PHARMACEUTICALS IN |
1,150,000 |
+48,096 |
$40,917 | | CRNX | 1,150,000 | +48,096 | $40,917 | | APELLIS PHARMACEUTICALS INC |
625,000 |
-1,375,000 |
$37,412 | | APLS | 625,000 | -1,375,000 | $37,412 | | MARINUS PHARMACEUTICALS INC |
3,250,000 |
+625,000 |
$35,328 | | MRNS | 3,250,000 | +625,000 | $35,328 | | AUTOLUS THERAPEUTICS PLC |
5,450,000 |
+5,057,833 |
$35,098 | | AUTL | 5,450,000 | +5,057,833 | $35,098 | | OLEMA PHARMACEUTICALS INC |
2,456,800 |
-2,047,964 |
$34,469 | | OLMA | 2,456,800 | -2,047,964 | $34,469 | | IMMUNEERING CORP |
4,204,364 |
UNCH |
$30,902 | | IMRX | 4,204,364 | UNCH | $30,902 | | EDGEWISE THERAPEUTICS INC |
2,551,989 |
-394,898 |
$27,919 | | EWTX | 2,551,989 | -394,898 | $27,919 | | AEROVATE THERAPEUTICS INC |
1,211,696 |
-350,000 |
$27,421 | | AVTE | 1,211,696 | -350,000 | $27,421 | | CARGO THERAPEUTICS INC |
1,182,563 |
+1,182,563 |
$27,376 | | CRGX | 1,182,563 | +1,182,563 | $27,376 | | HARPOON THERAPEUTICS INC |
2,349,060 |
+2,295,000 |
$26,709 | | HARP | 2,349,060 | +2,295,000 | $26,709 | | SYNDAX PHARMACEUTICALS INC |
1,175,000 |
+1,175,000 |
$25,392 | | SNDX | 1,175,000 | +1,175,000 | $25,392 | | KORRO BIO INC |
529,170 |
+529,170 |
$25,363 | | KRRO | 529,170 | +529,170 | $25,363 | | RHYTHM PHARMACEUTICALS INC |
550,000 |
-300,000 |
$25,284 | | RYTM | 550,000 | -300,000 | $25,284 | | ABIVAX SA |
2,130,000 |
+2,130,000 |
$22,791 | | ABVX | 2,130,000 | +2,130,000 | $22,791 | | INSMED INC |
575,000 |
UNCH |
$17,819 | | INSM | 575,000 | UNCH | $17,819 | | IDEAYA BIOSCIENCES INC |
450,000 |
-150,000 |
$16,011 | | IDYA | 450,000 | -150,000 | $16,011 | | AXONICS INC |
250,000 |
UNCH |
$15,558 | | AXNX | 250,000 | UNCH | $15,558 | | NEUROGENE INC |
746,180 |
+746,180 |
$14,461 | | NGNE | 746,180 | +746,180 | $14,461 | | LONGBOARD PHARMACEUTICALS IN |
2,353,141 |
UNCH |
$14,189 | | LBPH | 2,353,141 | UNCH | $14,189 | | PRAXIS PRECISION MEDICINES I |
633,345 |
-8,866,655 |
$14,111 | | PRAX | 633,345 | -8,866,655 | $14,111 | | ROCKET PHARMACEUTICALS INC |
450,000 |
UNCH |
$13,486 | | RCKT | 450,000 | UNCH | $13,486 | | RAPT THERAPEUTICS INC |
496,750 |
+171,750 |
$12,344 | | RAPT | 496,750 | +171,750 | $12,344 | | SPYRE THERAPEUTICS INC |
937,080 |
+937,080 |
$11,254 | | AGLE | 937,080 | +937,080 | $11,254 | | DISC MEDICINE INC |
125,000 |
-100,000 |
$7,220 | | IRON | 125,000 | -100,000 | $7,220 | | STOKE THERAPEUTICS INC |
1,087,807 |
UNCH |
$5,722 | | STOK | 1,087,807 | UNCH | $5,722 | | VERVE THERAPEUTICS INC |
350,000 |
UNCH |
$4,879 | | VERV | 350,000 | UNCH | $4,879 | | LANTHEUS HLDGS INC |
75,000 |
+75,000 |
$4,650 | | LNTH | 75,000 | +75,000 | $4,650 | | CENTESSA PHARMACEUTICALS PLC |
561,600 |
UNCH |
$4,470 | | CNTA | 561,600 | UNCH | $4,470 | | BIOHAVEN LTD |
81,963 |
UNCH |
$3,508 | | BHVN | 81,963 | UNCH | $3,508 | | GH RESEARCH PLC |
593,043 |
UNCH |
$3,440 | | GHRS | 593,043 | UNCH | $3,440 | | VYNE THERAPEUTICS INC |
1,394,336 |
+1,394,336 |
$3,249 | | VYNE | 1,394,336 | +1,394,336 | $3,249 | | BIOATLA INC |
1,181,115 |
UNCH |
$2,906 | | BCAB | 1,181,115 | UNCH | $2,906 | | NEUMORA THERAPEUTICS INC. |
92,293 |
UNCH |
$1,574 | | NMRA | 92,293 | UNCH | $1,574 |
See Full List: All Stocks Held By Cormorant Asset Management LP
— Including:
• Biggest new positions
• Biggest exits
• Biggest increased positions
• Biggest decreased positions
See Details: Top 10 Stocks Held By Cormorant Asset Management LP
|
|
